Clinical Trial Update: Elidel-Study: Elidel in Patients With Atopic Dermatitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Elidel (pimecrolimus) in patients with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Elidel (pimecrolimus)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED